Publicação

Are we aiming for different metabolic targets in heart failure patients?

Ver documento

Detalhes bibliográficos
Resumo:Introduction: Metabolic control plays an important role on major cardiovascular events (MACE) prevention. The 2019 ESC guidelines on dyslipidaemia management recommend tighter LDL-cholesterol (LDL-C) control in order to prevent cardiovascular events. However, it is not yet proven that thigh control of dyslipidaemia, glycaemic levels and body mass index (BMI) in Heart Failure (HF) patients (pts) have an impact on prognosis. Objective: To evaluate the impact of LDL-C, HbA1c and BMI values on HF pts mortality and MACE rates.
Autores principais:Brito, J.
Outros Autores:Agostinho, João R.; Duarte, C.; Silva, B.; Couto Pereira, Sara Cristina; Morais, Pedro; Cunha, Nelson; Rodrigues, Tiago; Antonio, P. S.; Santos, R.; Nunes-Ferreira, Afonso; Rigueira, Joana; Aguiar-Ricardo, Inês; Pinto, Fausto J.; Brito, Dulce
Assunto:Chronic heart failure Lifestyle modification
Ano:2020
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso restrito
Instituição associada:Universidade de Lisboa
Idioma:inglês
Origem:Repositório da Universidade de Lisboa
Descrição
Resumo:Introduction: Metabolic control plays an important role on major cardiovascular events (MACE) prevention. The 2019 ESC guidelines on dyslipidaemia management recommend tighter LDL-cholesterol (LDL-C) control in order to prevent cardiovascular events. However, it is not yet proven that thigh control of dyslipidaemia, glycaemic levels and body mass index (BMI) in Heart Failure (HF) patients (pts) have an impact on prognosis. Objective: To evaluate the impact of LDL-C, HbA1c and BMI values on HF pts mortality and MACE rates.